PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 35 filers reported holding PROQR THRAPEUTICS N V in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $75,032 | -85.0% | 57,717 | -81.3% | 0.00% | -100.0% |
Q2 2023 | $501,323 | -62.5% | 309,459 | -50.6% | 0.00% | -66.7% |
Q1 2023 | $1,335,352 | -14.2% | 626,926 | +49.0% | 0.00% | -25.0% |
Q4 2022 | $1,556,275 | +2729.6% | 420,615 | +472.8% | 0.00% | – |
Q3 2022 | $55,000 | -58.6% | 73,430 | -57.1% | 0.00% | – |
Q2 2022 | $133,000 | -93.7% | 171,172 | -46.1% | 0.00% | -100.0% |
Q1 2021 | $2,100,000 | +122.2% | 317,705 | +389.6% | 0.01% | -16.7% |
Q3 2015 | $945,000 | -12.7% | 64,886 | 0.0% | 0.01% | -14.3% |
Q2 2015 | $1,082,000 | -23.8% | 64,886 | 0.0% | 0.01% | -26.3% |
Q1 2015 | $1,420,000 | +12.2% | 64,886 | +11.1% | 0.02% | +11.8% |
Q4 2014 | $1,266,000 | -35.2% | 58,417 | -48.6% | 0.02% | -39.3% |
Q3 2014 | $1,954,000 | – | 113,676 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
Atom Investors LP | 18,522 | $68,531 | 0.03% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |